华神科技(000790) - 2025 Q2 - 季度业绩预告

Chengdu Huashen Technology Group Co., Ltd. 2025 Semi-Annual Performance Forecast Estimated Performance for the Current Period The company projects a net loss of 45 million to 55 million yuan for H1 2025, contrasting with a 9.11 million yuan profit in H1 2024 Key Financial Indicators | Item | Current Reporting Period (H1 2025) | Prior Year Period (H1 2024) | | :--- | :--- | :--- | | Net Profit Attributable to Shareholders | Loss: 45.00 million – 55.00 million yuan | Profit: 9.11 million yuan | | Net Profit After Non-Recurring Items | Loss: 46.00 million – 56.00 million yuan | Profit: 8.54 million yuan | Communication with Accounting Firm The company has pre-communicated the performance forecast with its accounting firm, finding no major disagreements, but the data remains unaudited preliminary estimates - This performance forecast data represents preliminary estimates by the company's finance department and has not been audited by the accounting firm[3] - The company has pre-communicated with the accounting firm regarding the performance forecast, and there are no significant disagreements between the parties[3] Explanation of Performance Changes The performance decline is primarily attributed to reduced core drug profitability from centralized procurement, scaled-back non-core architectural steel business, and increased new production base expenses - The profit contribution from the main product, Sanqi Tongshu Capsules, declined due to its selection in the national centralized procurement of traditional Chinese medicines[4] - To focus on its core business, the company proactively reduced the scale of its architectural steel structure business, leading to a year-on-year decrease in its output value and profit contribution[4] - Increased trial production expenses and depreciation and amortization from the Shandong Lingkai production base impacted current period profit[4] Risk Warning Investors are cautioned that this performance forecast is an unaudited preliminary estimate, with final financial data to be disclosed in the 2025 semi-annual report, urging prudent investment decisions - This performance forecast represents preliminary estimates by the company's finance department and has not yet been audited by an auditing firm[5] - Specific financial data will be detailed in the company's 2025 semi-annual report, and investors are advised to make cautious decisions and be aware of investment risks[5]